Stock A005250 GREEN CROSS HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Green Cross Holdings Corporation

Equities

A005250

KR7005250006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
15,350 KRW -2.10% Intraday chart for Green Cross Holdings Corporation -3.40% -6.12%
03/05 Green Cross Widens Q1 Loss, Sales Inch Up 2% MT
20/03 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 11,37,466 10,09,178 19,04,748 12,38,276 7,75,668 7,45,892
Enterprise Value (EV) 1 16,58,608 16,62,963 24,81,633 18,85,666 16,33,562 18,29,947
P/E ratio 61.8 x 379 x 11.1 x 22.6 x 23.8 x -13.6 x
Yield 1% 1.46% 1.2% 1.47% 1.76% 1.83%
Capitalization / Revenue 0.73 x 0.66 x 1.11 x 0.67 x 0.37 x 0.36 x
EV / Revenue 1.07 x 1.09 x 1.44 x 1.02 x 0.79 x 0.89 x
EV / EBITDA 17.2 x 19 x 20.1 x 12.7 x 11 x 25.1 x
EV / FCF -21.2 x -13.7 x -27.1 x -52.3 x 2,448 x -10.2 x
FCF Yield -4.71% -7.28% -3.69% -1.91% 0.04% -9.84%
Price to Book 0.01 x 1.24 x 2.05 x 1.21 x 0.74 x 0.76 x
Nbr of stocks (in thousands) 45,402 45,402 45,402 45,402 45,402 45,402
Reference price 2 25,100 22,250 41,500 27,150 17,000 16,350
Announcement Date 19/03/19 17/03/20 17/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 15,48,715 15,24,799 17,19,326 18,40,559 20,79,560 20,57,936
EBITDA 1 96,594 87,330 1,23,495 1,48,443 1,48,876 73,017
EBIT 1 49,312 30,388 70,664 85,999 70,221 -21,830
Operating Margin 3.18% 1.99% 4.11% 4.67% 3.38% -1.06%
Earnings before Tax (EBT) 1 43,189 -13,760 1,07,919 1,80,013 29,629 -81,110
Net income 1 18,467 2,957 1,70,960 55,270 32,823 -54,136
Net margin 1.19% 0.19% 9.94% 3% 1.58% -2.63%
EPS 2 406.5 58.73 3,743 1,201 715.6 -1,203
Free Cash Flow 1 -78,148 -1,20,998 -91,539 -36,032 667.4 -1,79,994
FCF margin -5.05% -7.94% -5.32% -1.96% 0.03% -8.75%
FCF Conversion (EBITDA) - - - - 0.45% -
FCF Conversion (Net income) - - - - 2.03% -
Dividend per Share 2 250.0 325.0 500.0 400.0 300.0 300.0
Announcement Date 19/03/19 17/03/20 17/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 5,21,143 6,53,785 5,76,885 6,47,390 8,57,894 10,84,055
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 5.395 x 7.486 x 4.671 x 4.361 x 5.762 x 14.85 x
Free Cash Flow 1 -78,148 -1,20,998 -91,539 -36,032 667 -1,79,994
ROE (net income / shareholders' equity) 1.34% -2.06% 4.43% 7.12% 3.04% -3.72%
ROA (Net income/ Total Assets) 1.19% 0.7% 1.47% 1.6% 1.24% -0.37%
Assets 1 15,54,684 4,20,689 1,16,42,626 34,64,319 26,50,866 1,45,44,950
Book Value Per Share 2 17,20,377 17,903 20,248 22,473 22,857 21,591
Cash Flow per Share 2 5,36,409 3,887 9,858 7,354 4,595 3,844
Capex 1 1,17,998 1,38,929 1,08,477 1,16,600 73,216 89,962
Capex / Sales 7.62% 9.11% 6.31% 6.34% 3.52% 4.37%
Announcement Date 19/03/19 17/03/20 17/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
GREEN CROSS HOLDINGS CORPORATION Stock Green Cross Holdings Corporation
-6.12% 513M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 200B
AMGEN INC. Stock Amgen Inc.
+10.77% 167B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A005250 Stock
  4. Financials Green Cross Holdings Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW